Literature DB >> 31019181

Worldwide Incidence of Peripartum Cardiomyopathy and Overall Maternal Mortality.

Toshiaki Isogai1, Chizuko A Kamiya2.   

Abstract

Peripartum cardiomyopathy (PPCM) is a specific cardiomyopathy in which heart failure develops due to reduced myocardial contraction during pregnancy or in the postpartum period in women without a previous history of heart disease. The epidemiology of PPCM has been reported in various countries and areas, and the incidence of PPCM differed among these reports. The incidence was highest (1 in 102 deliveries) in Nigeria and lowest (1 in 15,533 births) in Japan. The incidence was higher in African-Americans than in other races in several reports from the United States, and was also high in African countries and Haiti, indicating that the risk for PPCM is highest in the black race. However, the study design and definition of PPCM differ among studies, and these differences may influence the incidence. Moreover, the incidence of PPCM and the maternal mortality rate were well correlated. Since maternal mortality reflects the level of perinatal health care and hygiene, this finding suggests that the extent of perinatal care is partly related to the incidence of PPCM, which reflects heart failure and cardiomyopathy of unknown cause in women.

Entities:  

Keywords:  Epidemiology; Heart failure; Maternal health care; Pregnancy

Mesh:

Year:  2019        PMID: 31019181     DOI: 10.1536/ihj.18-729

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  11 in total

Review 1.  A bibliometric review of peripartum cardiomyopathy compared to other cardiomyopathies using artificial intelligence and machine learning.

Authors:  M Grosser; H Lin; M Wu; Y Zhang; S Tipper; D Venter; J Lu; C G Dos Remedios
Journal:  Biophys Rev       Date:  2022-02-09

Review 2.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

3.  In Reply.

Authors:  Susanne Schrey-Petersen
Journal:  Dtsch Arztebl Int       Date:  2022-01-28       Impact factor: 8.251

4.  Racial disparities in peripartum cardiomyopathy: eighteen years of observations.

Authors:  Rachel G Sinkey; Indranee N Rajapreyar; Jeff M Szychowski; Emily K Armour; Zachary Walker; Marc G Cribbs; Tera F Howard; Luisa A Wetta; Akila Subramaniam; Alan T Tita
Journal:  J Matern Fetal Neonatal Med       Date:  2020-06-07

5.  Peripartum Cardiomyopathy During Puerperium Co-existing with Pre-eclampsia and Complicated by Acute Renal Failure: A Case Report.

Authors:  Arshia Akbar; Hafiz Muhammad Ata Ur-Rehman; Asim Tameez Ud Din; Aimen Malik
Journal:  Cureus       Date:  2019-12-07

6.  Acute kidney injury predicts poor left ventricular function for patients with peripartum cardiomyopathy.

Authors:  Jiajia Zhu; Wenxian Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-04-22       Impact factor: 2.298

7.  Global, Regional, and National Burden of Myocarditis and Cardiomyopathy, 1990-2017.

Authors:  Haijiang Dai; Dor Lotan; Arsalan Abu Much; Arwa Younis; Yao Lu; Nicola Luigi Bragazzi; Jianhong Wu
Journal:  Front Cardiovasc Med       Date:  2021-02-11

8.  Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy.

Authors:  Ryan Cooney; John R Scott; Madeline Mahowald; Elizabeth Langen; Garima Sharma; David P Kao; Melinda B Davis
Journal:  Clin Cardiol       Date:  2022-02-07       Impact factor: 2.882

Review 9.  Current Desensitization Strategies in Heart Transplantation.

Authors:  Marlena V Habal
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 8.786

10.  Diagnostic dilemma: COVID-19 related cardiomyopathy or peripartum cardiomyopathy?

Authors:  Akinyemi A Akintayo; Basilio Addo; Saheed O Soleye; Dipal Patel; Ayesha Ahmad; Shraddha Tongia
Journal:  J Cardiol Cases       Date:  2021-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.